Global Tretinoin Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

Tretinoin is the pharmaceutical form of retinoic acid. One of several retinoids, it is the carboxylic acid form of vitamin A and is also known as all-trans retinoic acid (ATRA). It is a first generation topical retinoid commonly used topically to treat acne vulgaris. It is also used orally to treat acute promyelocytic leukemia (APL). Its isomer, isotretinoin, is also an acne drug. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.

Market Segment by Manufacturers, this report covers

BASF, LGM Pharma, GF Health, Gyma Laboratories, Genemed Synthesis, IMCoPharma, Chongqing Huabang, Olon S.p.A., Sun Pharma.

Market Analysis and Insights: Global Tretinoin Market
In 2020, the global Tretinoin market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Tretinoin Scope and Market Size
The global Tretinoin market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Tretinoin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
0.1% Tretinoin
0.02% Tretinoin
0.025% Tretinoin
0.05% Tretinoin

Segment by Application
Skin Disease
Leukemia

By Company
BASF
LGM Pharma
GF Health
Gyma Laboratories
Genemed Synthesis
IMCoPharma
Chongqing Huabang
Olon
Sun Pharma.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE